ABOUT OPHARMIC
Opharmic Technology (former Sonikure Technology) is a privately held medical technology company developing novel ocular drug delivery technology and devices. The company was founded in 2016 based on a patented ultrasound-mediated ocular drug delivery technology from the Hong Kong University of Science and Technology. With safety and feasibility well-demonstrated in pre-clinical studies, the technology non-invasively delivers large molecules (up to 70kDa) to the posterior eye segment through the sclera. With the vision to replace invasive intravitreal injections, Opharmic is currently in preparation of two large-scale pre-clinical studies in Q2-Q4 2018 to streamline product development, and to validate additional technology applications.
Awards & Recognitions
Awards & Recognitions
- Deloitte Raising Star Award - 2017
- 45th International Exhibition of Invention Geneva - Prize of the State of Geneva; Prize of ULBS Romania - 2017
- IET Innovation Award - 2016 Winner (Healthcare)
- Google We Solve for X - Moonshot Project
- Kairos' Society K50 - 2015 Global Top 50 Startups
- Rice Business Plan Competition - 2015 Top 6 Semi-finalist
- TiE International Business Plan Competition - 2015 Winner (Hong Kong & Asia); Asia Rising Star Award
- The HKUST 4th Annual One Million Dollar Entrepreneurship Competition - 2nd Prize Winner
|
Publications & Presentations
      |
Vertical Divider
|
In the press
      |
Vertical Divider